Somerset Indus Closes USD 288 Mn Fund III to Back Scalable Healthcare Ventures
Somerset typically invests between USD 15 million and USD 40 million in each portfolio company.
freepik
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
Somerset Indus Capital Partners has announced the successful closure of its third fund, Fund III, at USD 288 million, surpassing its initial target of USD 250 million.
The fundraise saw participation from a wide mix of global institutional investors, including development finance institutions, investment firms, domestic financial institutions, insurance companies, family offices, and impact investors from regions such as Europe, US, and Southeast Asia.
With Fund III, the firm will continue to focus on improving healthcare access for India’s “missing middle,” particularly in tier II and tier III cities. The fund aims to invest in scalable healthcare businesses that provide affordable and quality services across segments such as healthcare delivery, pharmaceuticals, medical devices, diagnostics, and related sectors.
Somerset typically invests between USD 15 million and USD 40 million in each portfolio company. However, it retains the flexibility to participate in larger deals of up to USD 60–80 million through co-investments alongside its limited partner network.
The new fund will also support opportunities in areas such as preventive care, OPD-linked insurance, healthcare financing, embedded insurance solutions, generics, medical technology innovation, and diagnostics platforms that improve access beyond metro markets.
Fund III has already made three investments in Cyrix Healthcare, Printmann Offset, and NU Hospitals.
Somerset’s earlier funds have also reported strong returns. Fund I delivered around 4.0x DPI, while Fund II is progressing toward exits, with its first realisation completed in September 2025 at nearly 4x MOIC.
Founded in 2011, Somerset Indus Capital Partners is a healthcare-focused private equity firm managing approx. USD 500 million in assets across three funds, with a focus on expanding access to affordable healthcare in underserved markets.
Somerset Indus Capital Partners has announced the successful closure of its third fund, Fund III, at USD 288 million, surpassing its initial target of USD 250 million.
The fundraise saw participation from a wide mix of global institutional investors, including development finance institutions, investment firms, domestic financial institutions, insurance companies, family offices, and impact investors from regions such as Europe, US, and Southeast Asia.
With Fund III, the firm will continue to focus on improving healthcare access for India’s “missing middle,” particularly in tier II and tier III cities. The fund aims to invest in scalable healthcare businesses that provide affordable and quality services across segments such as healthcare delivery, pharmaceuticals, medical devices, diagnostics, and related sectors.
